Lumito AB

Lumito AB

Lumito AB

Overview
Date Founded

2010

Headquarters

Mårtenstorget 5,Lund, Skane 223 51

Type of Company

Public

Employees (Worldwide)

7

Industries

Other Business & Consulting Services
Medical Products & Equipment

Company Description

Lumito AB engages in the development, manufacturing, and licensing of imaging products based on nanoparticles. It offers analysis instrument and reagents to the healthcare sector. The company was founded by Per Stefan Andersson-Engels on December 10, 2010 and is headquartered in Lund, Sweden.

Contact Data
Trying to get in touch with decision makers at Lumito AB? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chairman & Chief Executive Officer

Chief Financial Officer

Director

Board of Directors

Chairman & Chief Executive Officer at Lumito AB

Director-Biophotonics at Tyndall National Institute

Director at SpectraCure AB

Chairman at Reccan Diagnostics AB

Paths to Lumito AB
Potential Connections via
Relationship Science
You
Lumito AB
Recent Transactions
Details Hidden

purchases Lumito AB

Transaction Advisors
Investment Advisor

Advised on purchases Lumito AB

Key Stats and Financials As of 2020
Market Capitalization
$21.2M
Total Enterprise Value
$34.6M
Earnings Per Share
$-0.02
Three Year Compounded Annual Growth Rate Of Revenue
0%
Revenue
$0
Net Profit
$-1.71M
EBITDA
$-1.75M
Total Debt
$0
Total Equity
$10M
Debt TEV
0x
TEVNet Income
-20.17x
Investors
Details Hidden

Director-Biophotonics at Tyndall National Institute

Details Hidden

LU Holding's investment strategy focuses on innovations and projects needing start-up, early-stage or early expansion capital. Their investment objective has a stringent commercial focus. Their goal is to create value growth for the inventors, Lund University, the investors and society. Their primary geographic focus is Sweden.The firm is an active investment partner which has invested in projects and spin-out firms active in areas such as supervisory and control applications that optimize the production of biogas, mobile communications and intelligent surveillance, Web-based platform for distance learning, computer assisted diagnostic software for nuclear medicine, medical devices for colorectal surgery, algorithms for faster graphics hardware, antibody drug projects within the areas of thrombosis, cancer, atherosclerosis and ophthalmic diseases, peptide therapeutics, analytical separation techniques, and proteomic research for mass spectrometry analysis.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Lumito AB. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Lumito AB's profile does not indicate a business or promotional relationship of any kind between RelSci and Lumito AB.